Surgery Partners, Inc. $SGRY Position Reduced by Empowered Funds LLC

Empowered Funds LLC trimmed its position in Surgery Partners, Inc. (NASDAQ:SGRY) by 32.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 108,491 shares of the company’s stock after selling 52,928 shares during the quarter. Empowered Funds LLC’s holdings in Surgery Partners were worth $1,293,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in the company. Janus Henderson Group PLC lifted its position in shares of Surgery Partners by 3.8% in the 4th quarter. Janus Henderson Group PLC now owns 13,537,984 shares of the company’s stock valued at $209,162,000 after acquiring an additional 501,401 shares in the last quarter. Pentwater Capital Management LP grew its position in Surgery Partners by 66.9% during the 3rd quarter. Pentwater Capital Management LP now owns 11,681,000 shares of the company’s stock worth $252,777,000 after purchasing an additional 4,681,000 shares in the last quarter. UBS Group AG grew its position in Surgery Partners by 111.4% during the 4th quarter. UBS Group AG now owns 7,803,974 shares of the company’s stock worth $120,571,000 after purchasing an additional 4,113,052 shares in the last quarter. Dimensional Fund Advisors LP grew its position in Surgery Partners by 7.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 5,296,411 shares of the company’s stock worth $63,131,000 after purchasing an additional 389,831 shares in the last quarter. Finally, Goldman Sachs Group Inc. raised its stake in Surgery Partners by 528.2% during the 4th quarter. Goldman Sachs Group Inc. now owns 1,959,686 shares of the company’s stock valued at $30,277,000 after purchasing an additional 1,647,714 shares during the period.

Surgery Partners Price Performance

NASDAQ SGRY opened at $15.53 on Friday. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.86 and a quick ratio of 1.69. The firm has a market capitalization of $2.03 billion, a price-to-earnings ratio of -25.88, a price-to-earnings-growth ratio of 4.64 and a beta of 1.91. The company has a 50 day simple moving average of $15.43 and a 200-day simple moving average of $14.44. Surgery Partners, Inc. has a 52-week low of $11.41 and a 52-week high of $24.10.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on SGRY. Zacks Research upgraded Surgery Partners from a “hold” rating to a “strong-buy” rating in a report on Thursday, June 4th. Jefferies Financial Group reiterated a “buy” rating and set a $17.00 price target on shares of Surgery Partners in a report on Wednesday, May 6th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Surgery Partners in a research report on Tuesday, May 26th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $21.60.

Surgery Partners Company Profile

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.